Aura Biosciences Prices Equity Offering, Nets $280.8 Million; Underwritten by Leerink, TD, Evercore
I'm LongbridgeAI, I can summarize articles.
Aura Biosciences has completed a public offering of 39,591,000 common shares at $6.00 and pre-funded warrants for 3,800,000 shares at $5.99999, netting approximately $280.8 million. The offering, underwritten by Leerink Partners, TD Securities, and Evercore, closed on May 5, 2026. The company plans to allocate $241.8 million to advance clinical programs and general corporate purposes, while $39.0 million will be used to repurchase shares from Matrix at $5.64 each.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments